HP
RUBY

Harbourvest Partners’s Rubius Therapeutics, Inc RUBY Stock Holding History

Harbourvest Partners’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-986,878
Closed -$173K – 71
2022
Q4 		$173K Hold
986,878
– – 0.06% 54
2022
Q3 		$428K Hold
986,878
– – 0.14% 49
2022
Q2 		$840K Hold
986,878
– – 0.28% 42
2022
Q1 		$5.44M Hold
986,878
– – 1.11% 17
2021
Q4 		$9.55M Hold
986,878
– – 1.22% 12
2021
Q3 		$17.6M Hold
986,878
– – 1.66% 9
2021
Q2 		$24.1M Hold
986,878
– – 2.3% 6
2021
Q1 		$26.2M Hold
986,878
– – 3.51% 5
2020
Q4 		$7.49M Hold
986,878
– – 2.93% 7
2020
Q3 		$4.94M Hold
986,878
– – 1.83% 7
2020
Q2 		$5.9M Hold
986,878
– – 2.54% 7
2020
Q1 		$4.39M Hold
986,878
– – 2.12% 6
2019
Q4 		$9.38M Hold
986,878
– – 3.86% 3
2019
Q3 		$7.75M Hold
986,878
– – 3.22% 6
2019
Q2 		$15.5M Hold
986,878
– – 5.69% 4
2019
Q1 		$17.9M Hold
986,878
– – 6.32% 2
2018
Q4 		$15.9M Hold
986,878
– – 7.52% 3
2018
Q3 		$23.7M Buy
+986,878
New +$22.6M 21.41% 1

Other funds holding RUBY

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Harbourvest Partners's RUBY Position: Q1 2023 in Review

Harbourvest Partners sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 986,878 shares — an estimated $173K sold.

Harbourvest Partners first reported a position in RUBY in Q3 2018 and held it in 18 quarters. The position peaked at $26.2M in Q1 2021. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Harbourvest Partners reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Harbourvest Partners sold 986,878 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $173K.
  • Harbourvest Partners first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 18 quarters.
  • Harbourvest Partners's Rubius Therapeutics, Inc position peaked at $26.2M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Harbourvest Partners's 13F filing for Q1 2023, filed 15 May 2023.